Validation and Pertinence of Anxiety Analogic Visual Scale in Pain Management

Not Applicable

Completed

• Conditions: Pain; Anxiety
• Interventions: Other: Anxiety visual analog scale

• Registration Number: NCT02690597
• Lead Sponsor: University Hospital, Toulouse

Brief Summary

Screening of anxiogenic part of pain is an imperative during a medical pain consultation. The actual tools for evaluation of this specific part are complex and time consuming.

To date, it lacked a reliable and reproductive tool to quickly evaluate anxiety of patient in pain. The purpose of this study is to demonstrate the pertinence and validity of anxiety analogic visual scale by comparison with the actual reference the self-assessment questionnaire State Trait Inventory Anxiety Y-A form.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-02
• Study First Submitted: 2016-02-05
• Study First Submitted QC: 2016-02-23
• Study First Posted: 2016-02-24
• Primary Completion: 2016-12
• Study Completion: 2016-12
• Status Verified: 2018-11
• Last Update Submitted: 2018-11-29
• Last Update Posted: 2018-12-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 55

Inclusion Criteria

• Signed and dated informed consent
• Male or female aged from ≥ 18 years old
• Perfect patient ability to understand and write French
• Patient with a pain threshold permitting a initial medication free consultation and completion of anxiety surveys.

Exclusion Criteria

• Inability of patient to understand the study procedures and thus inability to give informed consent.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Patient	Anxiety visual analog scale	State-trait anxiety inventory Y-A form (STAI Y-A form) Anxiety visual analog scale evaluation(A-AVS).

Primary Outcome Measures

Name	Time	Method
Evaluation of pertinence of anxiety analogic visual scale in systematic use as assessed by anxiety levels obtained with State Trait of anxiety Y-A form score	Baseline	The patient's inclusion take place during the only study participation day of the patient
Evaluation of validity of anxiety analogic visual scale in systematic use as assessed by anxiety levels obtained with State Trait of anxiety Y-A form score	Baseline	The patient's inclusion take place during the only study participation day of the patient
Evaluation of pertinence of anxiety analogic visual scale in systematic use as assessed by anxiety levels obtained with anxiety analogic visual scale score	Baseline	The patient's inclusion take place during the only study participation day of the patient
Evaluation of validity of anxiety analogic visual scale in systematic use as assessed by anxiety levels obtained with anxiety analogic visual scale score	Baseline	The patient's inclusion take place during the only study participation day of the patient

Secondary Outcome Measures

Name	Time	Method
Evaluation of pain consultation impact on anxiety part of pain as assessed by anxiety levels obtained with State Trait of anxiety Y-A form score	Baseline	The patient's inclusion take place during the only study participation day of the patient
Evaluation of pain consultation impact on anxiety part of pain as assessed by anxiety levels obtained with anxiety analogic visual scale score	Baseline	The patient's inclusion take place during the only study participation day of the patient
Evaluation of clinical utility of anxiety analogic visual scale in nursing care as assessed by anxiety levels obtained with State Trait of anxiety Y-A form score	Baseline	The patient's inclusion take place during the only study participation day of the patient
Evaluation of clinical utility of anxiety analogic visual scale in nursing care as assessed by anxiety levels anxiety analogic visual scale score	Baseline	The patient's inclusion take place during the only study participation day of the patient

Trial Locations

Locations (1)

CHU Rangueil; 🇫🇷 Toulouse, France